Target intelligence / Profile preview

NFKB1 antisense RNA 1 (NFKB1-AS1)

Target
NFKB1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

NFKB1-AS1 (ENSG00000260651) is a long non-coding RNA (lncRNA) transcribed antisense to the NFKB1 gene, which encodes the NF-κB p105/p50 transcription factor subunit involved in immune and inflammatory processes. As an antisense RNA, NFKB1-AS1 may have a regulatory function on NFKB1 gene expression, but its specific biological role, clinical significance, or involvement in disease remains largely uncharacterized. This transcript is not currently regarded as a canonical therapeutic target such as a receptor, enzyme, transporter, or ion channel[3]. Essential clarification: "NFKB1 antisense RNA 1" is not the same as "NFKB1," which is a key, druggable transcription factor implicated in immunity and disease[1][5][7]. The antisense transcript has not been established in the literature or databases as a validated target for drug discovery or biological intervention[3].

Other names
NFKB1 antisense RNA 1NFKB1-AS1ENSG00000260651
02

Biological functions

Regulation of gene expression (potential, inferred from class)Potential modulation of NFKB1 gene expression (general for antisense lncRNAs, not specific to this transcript)
03

Disease associations

Other

Beyond the preview

Go deeper on NFKB1 antisense RNA 1 (NFKB1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NFKB1 antisense RNA 1 (NFKB1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call